17.07.2013 19:01:52
|
DS Healthcare Reveals Positive Data From New Study
(RTTNews) - DS Healthcare Group Inc. (DSKX), a developer of personal care products, said Wednesday that a study of its Spectral.DNC-S containing a compound sourced as a byproduct of pine production showed that it is effective in the promotion of healthy hair and in the cessation of thinning hair in males.
Spectral.DNC-S addresses the $3.5 billion spent per year by Americans attempting to treat their hair loss. Spectral.DNC-S is a completely new innovation for the treatment of thinning hair.
The double-blind trial was conducted at Miami Dade Medical Center in Miami, Florida. The subjects were between the ages of 25 and 55 years and had been experiencing active thinning hair. Clinical assessment of scalps of volunteers showed that 85% of subjects had an increase in hair density and 17% had a dramatic improvement. 11% of subjects had no response.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DS Healthcare Group Incmehr Nachrichten
Keine Nachrichten verfügbar. |